Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Erythropoietin as an Adjuvant Treatment With (chemo) Radiation Therapy for Head and Neck Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434531/all/Gold_as_an_oral_corticosteroid_sparing_agent_in_stable_asthma:_Cochrane_systematic_review. Accessed 13 May 2024.
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434531/all/Gold_as_an_oral_corticosteroid_sparing_agent_in_stable_asthma:_Cochrane_systematic_review. Accessed May 13, 2024.
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434531/all/Gold_as_an_oral_corticosteroid_sparing_agent_in_stable_asthma:_Cochrane_systematic_review
Erythropoietin as an Adjuvant Treatment With (chemo) Radiation Therapy for Head and Neck Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 May 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434531/all/Gold_as_an_oral_corticosteroid_sparing_agent_in_stable_asthma:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
ID - 434531
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434531/all/Gold_as_an_oral_corticosteroid_sparing_agent_in_stable_asthma:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -